Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary

References

• Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., and Lucier, G. W. 1993. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85: 1159–1164.
   PubMed Web of Science ®Google Scholar
• Bolt, H. M. and Thier, R. 2006. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr. Drug Metab. 7: 613–628.
   PubMed Web of Science ®Google Scholar
• Brockmöller, J., Cascorbi, I., Kerb, R., and Roots, I. 1996. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res. 56: 3915–3925.
   PubMed Web of Science ®Google Scholar
• Engel, L. S., Taioli, E., Pfeiffer, R., Garcia-Closas, M., Marcus, P. M., Lan, Q., Boffetta, P., Vineis, P., Autrup, H., Bell, D. A., Branch, R. A., Brockmöller, J., Daly, A. K., Heckbert, S. R., Kalina, I., Kang, D., Katoh, T., Lafuente, A., Lin, H. J., Romkes, M., Taylor, J. A., and Rothman, N. 2002. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: A HuGE review. Am. J. Epidemiol. 156: 95–109. Erratum in: Am. J. Epidemiol. 156: 492.
   PubMed Web of Science ®Google Scholar
• Fernández, M. I., López, J. F., Vivaldi, B., and Coz, F. 2012. Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure. J. Urol. 187: 856–861.
   PubMed Web of Science ®Google Scholar
• Freedman, N. D., Silverman, D. T., Hollenbeck, A. R., Schatzkin, A., and Abnet, C. C. 2011. Association between smoking and risk of bladder cancer among men and women. J. Am. Med. Assoc. 306: 737–745.
   PubMed Web of Science ®Google Scholar
• García-Closas, M., Hein, D. W., Silverman, D., Malats, N., Yeager, M., Jacobs, K., Doll, M. A., Figueroa, J. D., Baris, D., Schwenn, M., Kogevinas, M., Johnson, A., Chatterjee, N., Moore, L. E., Moeller, T., Real, F. X., Chanock, S., and Rothman, N. 2011a. A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. Pharmacogenet. Genomics 21: 231–236.
   PubMed Web of Science ®Google Scholar
• García-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D. W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Castaño-Vinyals, G., Yeager, M., Welch, R., Chanock, S., Chatterjee, N., Wacholder, S., Samanic, C., Torà, M., Fernández, F., Real, F. X., and Rothman, N. 2005. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366: 649–659.
   PubMed Web of Science ®Google Scholar
• Garcia-Closas, M., Ye, Y., Rothman, N., Figueroa, J. D., Malats, N., Dinney, C. P., Chatterjee, N., Prokunina-Olsson, L., Wang, Z., Lin, J., Real, F. X., Jacobs, K. B., Baris, D., Thun, M., De Vivo, I., Albanes, D., Purdue, M. P., Kogevinas, M., Kamat, A. M., Lerner, S. P., Grossman, H. B., Gu, J., Pu, X., Hutchinson, A., Fu, Y. P., Burdett, L., Yeager, M., Tang, W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Johnson, A., Schwenn, M., Karagas, M. R., Schned, A., Andriole, G., Jr., Grubb, R., 3rd, Black, A., Jacobs, E. J., Diver, W. R., Gapstur, S. M., Weinstein, S. J., Virtamo, J., Hunter, D. J., Caporaso, N., Landi, M. T., Fraumeni, J. F., Jr., Silverman, D. T., Chanock, S. J., and Wu, X. 2011b. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum. Mol. Genet. 20: 4282–4289.
   PubMed Web of Science ®Google Scholar
• Ginsberg, G., Smolenski, S., Hattis, D., Guyton, K. Z., and Sonawane, B. 2009. Genetic polymorphism in glutathione S-transferases (GST): Population distribution of GSTM1, T1 and P1 conjugating activity. J. Toxicol. Environ. Health B 12: 389–439.
   PubMed Web of Science ®Google Scholar
• Golka, K., Abreu-Villaca, Y., Anbari Attar, R., Angeli-Greaves, M., Aslam, M., Basaran, N., Belik, R., Butryee, C., Dalpiaz, O., Dzhusupov, K., Ecke, T. H., Galambos, H., Galambos, H., Gerilovica, H., Gerullis, H., Gonzalez, P. C., Goossens, M. E., Gorgishvili-Hermes, L., Heyns, C. F., Hodzic, J., Ikoma, F., Jichlinski, P., Kang, B. H., Kiesswetter, E., Krishnamurthi, K., Lehmann, M. L., Martinova, I., Mittal, R. D., Ravichandran, B., Romics, I., Roy, B., Rungkat-Zakaria, F., Rydzynski, K., Scutaru, C., Shen, J., Soufi, M., Toguzbaeva, K., Vu Duc, T., Widera, A., Wishahi, M., and Hengstler, J. G. 2012a. Bladder cancer documentation of causes: Multi-lingual questionnaire, ‘bladder cancer doc’. Front. Biosci. 4: 2809–2822.
   Google Scholar
• Golka, K., Hermes, M., Selinski, S., Blaszkewicz, M., Bolt, H. M., Roth, G., Dietrich, H., Prager, H. M., Ickstadt, K., and Hengstler, J. G. 2009. Susceptibility to urinary bladder cancer: Relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. Pharmacogenet. Genomics 19: 903–906.
   PubMed Web of Science ®Google Scholar
• Golka, K., Kopps, S., Prager, H. M., Mende, S. V., Thiel, R., Jungmann, O., Zumbe, J., Bolt, H. M., Blaszkewicz, M., Hengstler, J. G., and Selinski, S. 2012b. Bladder cancer in crack testers applying azo dye-based sprays to metal bodies. J. Toxicol. Environ. Health A 75: 566–571.
   PubMed Web of Science ®Google Scholar
• Golka, K., Prior, V., Blaszkewicz, M., and Bolt, H. M. 2002a. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: A review considering ethnic differences. Toxicol. Lett. 128: 229–241.
   PubMed Web of Science ®Google Scholar
• Golka, K., Prior, V., Blaszkewicz, M., Cascorbi, I., Schöps, W., Kierfeld, G., Roots, I., and Bolt, H. M. 1996. Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany. Scand. J. Work Environ. Health 22: 332–338.
   PubMed Web of Science ®Google Scholar
• Golka, K., Reckwitz, T., Kempkes, M., Cascorbi, I., Blaskewicz, M., Reich, S. E., Roots, I., Sökeland, J., Schulze, H., and Bolt, H. M. 1997. N-Acetyltransferase 2 (NAT2) and glutathione S-transferase μ (GSTM1) in bladder-cancer patients in a highly industrialized area. Int. J. Occup. Environ. Health 3: 105–110.
   PubMedGoogle Scholar
• Golka, K., Selinski, S., Lehmann, M. L., Blaszkewicz, M., Marchan, R., Ickstadt, K., Schwender, H., Bolt, H. M., and Hengstler, J. G. 2011. Genetic variants in urinary bladder cancer: Collective power of the “wimp SNPs”. Arch. Toxicol. 85: 539–554.
   PubMed Web of Science ®Google Scholar
• Golka, K., Weistenhöfer, W., Prior, V., Reckwitz, T., Seidel, T., Thier, R., Blaszkewicz, M., and Bolt, H. M. 2002b. Die Bedeutung der N-Acetyltransferase 2 als Prädispositionsfaktor für das Harnblasenkarzinom bei geringer Exposition gegen aromatische Amine. 42. Jahrestagung der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin e.V., 10.-13.04.2002 in München (S 373-375). Lübeck, Deutschland: DGAUM 2002b.
   Google Scholar
• Golka, K., Wiese, A., Assennato, G., and Bolt, H. M. 2004. Occupational exposure and urological cancer. World J. Urol. 21: 382–391.
   PubMed Web of Science ®Google Scholar
• Hung, R. J., Boffetta, P., Brennan, P., Malaveille, C., Hautefeuille, A., Donato, F., Gelatti, U., Spaliviero, M., Placidi, D., Carta, A., Scotto Di Carlo, A., and Porru, S. 2004. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int. J. Cancer 110: 598–604.
   PubMed Web of Science ®Google Scholar
• IARC International Agency for Research on Cancer. 1974. Some Aromatic Amines, Hydrazine and Related Substances, N-Nitroso Compounds and Miscellaneous Alkylating Agent. IARC Monogr. Eval. Carcinogen. Risk Chem. Man. Vol. 4: Lyon, France.
   Google Scholar
• Johns, L. E. and Houlston, R. S. 2000. Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: A meta-analysis. Mutagenesis 15: 399–404.
   PubMed Web of Science ®Google Scholar
• Kempkes, M., Golka, K., Reich, S., Reckwitz, T., and Bolt, H. M. 1996. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch. Toxicol. 71: 123–126.
   PubMed Web of Science ®Google Scholar
• Kopps, S., Angeli-Greaves, M., Blaszkewicz, M., Prager, H. M., Roemer, H. C., Lohlein, D., Weistenhofer, W., Bolt, H. M., and Golka, K. 2008. Glutathione S-transferase P1 ILE105Val polymorphism in occupationally exposed bladder cancer cases. J. Toxicol. Environ. Health Part A 71: 898–901.
   PubMed Web of Science ®Google Scholar
• Krech, E., Selinski, S., Blaszkewicz, M., Bürger, H., Kadhum, T., Hengstler, J. G., Truss, M. C., and Golka, K. 2017. Urinary bladder cancer risk factors in an area of former coal, iron and steel industries in Germany. J. Toxicol. Environ. Health Part A DOI: 10.1080/10937404.2017.1304719
   PubMedGoogle Scholar
• Li, N. and Stephens, M. 2003. Modelling Linkage Disequilibrium, and identifying recombination hotspots using SNP data. Genetics 165: 2213–2233.
   PubMed Web of Science ®Google Scholar
• Lower, G. M., Jr, Nilsson, T., Nelson, C. E., Wolf, H., Gamsky, T. E., and Bryan, G. T. 1979. N-Acetyltransferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ. Health Persp. 29: 71–79.
   PubMed Web of Science ®Google Scholar
• Moore, L. E., Baris, D. R., Figueroa, J. D., Garcia-Closas, M., Karagas, M. R., Schwenn, M. R., Johnson, A. T., Lubin, J. H., Hein, D. W., Dagnall, C. L., Colt, J. S., Kida, M., Jones, M. A., Schned, A. R., Cherala, S. S., Chanock, S. J., Cantor, K. P., Silverman, D. T., and Rothman, N. 2011. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: Results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 32: 182–189.
   PubMed Web of Science ®Google Scholar
• Ovsiannikov, D., Selinski, S., Lehmann, M. L., Blaszkewicz, M., Moormann, O., Haenel, M. W., Hengstler, J. G., and Golka, K. 2012. Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry. J. Toxicol. Environ. Health A 75: 557–565.
   PubMed Web of Science ®Google Scholar
• Rafnar, T., Vermeulen, S. H., Sulem, P., Thorleifsson, G., Aben, K. K., Witjes, J. A., Grotenhuis, A. J., Verhaegh, G. W., Hulsbergen-Van De Kaa, C. A., Besenbacher, S., Gudbjartsson, D., Stacey, S. N., Gudmundsson, J., Johannsdottir, H., Bjarnason, H., Zanon, C., Helgadottir, H., Jonasson, J. G., Tryggvadottir, L., Jonsson, E., Geirsson, G., Nikulasson, S., Petursdottir, V., Bishop, D. T., Chung-Sak, S., Choudhury, A., Elliott, F., Barrett, J. H., Knowles, M. A., De Verdier, P. J., Ryk, C., Lindblom, A., Rudnai, P., Gurzau, E., Koppova, K., Vineis, P., Polidoro, S., Guarrera, S., Sacerdote, C., Panadero, A., Sanz-Velez, J. I., Sanchez, M., Valdivia, G., Garcia-Prats, M. D., Hengstler, J. G., Selinski, S., Gerullis, H., Ovsiannikov, D., Khezri, A., Aminsharifi, A., Malekzadeh, M., Van Den Berg, L. H., Ophoff, R. A., Veldink, J. H., Zeegers, M. P., Kellen, E., Fostinelli, J., Andreoli, D., Arici, C., Porru, S., Buntinx, F., Ghaderi, A., Golka, K., Mayordomo, J. I., Matullo, G., Kumar, R., Steineck, G., Kiltie, A. E., Kong, A., Thorsteinsdottir, U., Stefansson, K., and Kiemeney, L. A. 2011. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum. Mol. Genet. 20: 4268–4281.
   PubMed Web of Science ®Google Scholar
• Rothman, N., Garcia-Closas, M., and Hein, D. W. 2007. Commentary: Reflections on G. M. Lower and colleagues’ 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned. Int. J. Epidemiol. 36: 23–28.
   PubMed Web of Science ®Google Scholar
• SAS/STAT® software, version 9.2. Copyright ©. 2002–2008. Cary, NC, USA: SAS Institute Inc .
   Google Scholar
• Selinski, S., Blaszkewicz, M., Getzmann, S., and Golka, K. 2015. N-Acetyltransferase 2: Ultra-slow acetylators enter the stage. Arch. Toxicol. 89: 2445–2447.
   PubMed Web of Science ®Google Scholar
• Selinski, S., Blaszkewicz, M., Ickstadt, K., Hengstler, J. G., and Golka, K. 2013. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk. Arch. Toxicol. 87: 2129–2139.
   PubMed Web of Science ®Google Scholar
• Stephens, M. and Donnelly, P. 2003. A comparison of Bayesian methods for haplotype reconstruction. Am. J. Human Genet. 73: 1162–1169.
   PubMed Web of Science ®Google Scholar
• Stephens, M., Smith, N. J., and Donnelly, P. 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68: 978–989.
   PubMed Web of Science ®Google Scholar
• Vineis, P., Marinelli, D., Autrup, H., Brockmoller, J., Cascorbi, I., Daly, A. K., Golka, K., Okkels, H., Risch, A., Rothman, N., Sim, E., and Taioli, E. 2001. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: A pooled analysis of genotype-based studies. Cancer Epidemiol. Biomarkers Prev. 10: 1249–1252.
   PubMed Web of Science ®Google Scholar
• Weistenhöfer, W., Blaszkewicz, M., Bolt, H. M., and Golka, K. 2008. N-Acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany. J. Toxicol. Environ. Health A 71: 906–910.
   PubMed Web of Science ®Google Scholar
• Wikipedia 2015. COMECON. https://en.wikipedia.org/wiki/Comecon ( Accessed July 1 2015).
   Google Scholar
• Zeegers, M. P., Tan, F. E., Dorant, E., and Van Den Brandt, P. A. 2000. The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies. Cancer 89: 630–639.
   PubMed Web of Science ®Google Scholar
• Zhang, R., Xu, G., Chen, W., and Zhang, W. 2011. Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: A meta-analysis of 26 studies. Mol. Biol. Rep. 38: 2491–2497.
   PubMed Web of Science ®Google Scholar